Interobserver Agreement of Electrode to Retina Distance Measurements in a Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis

Carla J Abbott, Elizabeth K Baglin, Maria Kolic, Myra B McGuinness, Samuel A Titchener, Kiera A Young, Jonathan Yeoh, Chi D Luu, Lauren N Ayton, Matthew A Petoe, Penelope J Allen, Carla J Abbott, Elizabeth K Baglin, Maria Kolic, Myra B McGuinness, Samuel A Titchener, Kiera A Young, Jonathan Yeoh, Chi D Luu, Lauren N Ayton, Matthew A Petoe, Penelope J Allen

Abstract

Purpose: The electrode to retina (ER) distance is an important contributory factor to the safety and efficacy of a suprachoroidal retinal prosthesis. Measuring ER distance may be performed by different observers during multisite studies. The aim of this study was to assess the interobserver agreement in measuring ER distance.

Methods: Three independent, trained observers measured ER distance from the center of each suprachoroidal electrode to the inner retinal pigment epithelium in spectral-domain optical coherence tomography (SD-OCT) B-scans. A total of 121 ER distance measurements from 77 B-scans collected over 5 months from one subject implanted with a second-generation 44-channel suprachoroidal retinal prosthesis (NCT03406416) were made by each observer.

Results: ER distance ranged from 208 to 509 µm. Pearson's correlation coefficient (ρ) showed agreement of 0.99 (95% confidence interval [CI] = 0.98-0.99) in measuring ER for each pairwise comparison. The mean difference in ER distance between observers ranged from 2.4 to 6.4 µm with pairwise limits of agreement (95% CI) of ±20 µm (5.5% of mean). Intraclass correlation coefficient (ICC) showed agreement of 0.98 (95% CI = 0.97-0.99) between observers.

Conclusions: There is high agreement in measuring ER distances for suprachoroidal retinal prostheses using our systematic approach between multiple, trained observers, supporting the use of a single observer for each image.

Translational relevance: High interobserver agreement outcomes indicate that multiple, trained observers can be used to take ER measurements across different images in suprachoroidal retinal prosthesis studies. This improves multisite study efficiency and gives confidence in interpreting results relating to the safety and efficacy of suprachoroidal retinal prostheses.

Conflict of interest statement

Disclosure: C.J. Abbott, Bionic Vision Technologies (F, R); E.K. Baglin, Bionic Vision Technologies (F, R); M. Kolic, Bionic Vision Technologies (F, R); M.B. McGuinness, None; S.A. Titchener, Bionic Vision Technologies (F); K.A. Young, None; J. Yeoh, None; C.D. Luu, None; L.N. Ayton, None; M.A. Petoe, Bionics Institute and Centre for Eye Research Australia (P), Bionic Vision Technologies (R); P.J. Allen, Bionics Institute and Centre for Eye Research Australia (P), Bionic Vision Technologies (F)

Figures

Figure 1.
Figure 1.
The second-generation, 44-channel, suprachoroidal retinal prosthesis. (A) Photograph of the retinal array showing the 44 stimulating platinum electrodes (Ø 1 mm) and 2 return platinum electrodes (Ø 2 mm) within a silicone substrate (19 × 8 mm). (B) Color fundus photograph showing the position of the array (dotted lines) implanted under the macula in the right eye of a subject with retinitis pigmentosa. Fovea = F.
Figure 2.
Figure 2.
Timeline that interobserver SD-OCT measures were taken (orange) within the overall second-generation retinal prosthesis clinical trial for this subject (not to scale). SD-OCT measures were part of the suite of clinical assessments performed 2 to 4 weekly in the first 6 months after surgery, then at approximately 12 weekly intervals after the device fitting and training was complete (§), until the trial end point at 2.8 years postsurgery. Yellow lightning sign = device switch on (day 62 postsurgery).
Figure 3.
Figure 3.
Electrode to retina (ER) distance measurement method. (A) IR image with green arrow indicating B-scan position aligned with the rows of the suprachoroidal electrode array. The accompanying SD-OCT B-scan image shows the position of the electrode array relative to the retina. (B) Magnified view of the region in the blue box in A, showing the inner retina, retinal pigment epithelium/Bruch's membrane (RPE/BM complex), choroid and suprachoroidal electrode, and the ER distance measurement (red line), measured perpendicularly from the center of the electrode to the inner RPE/BM complex.
Figure 4.
Figure 4.
Distribution of electrode to retina (ER) measurements for each observer. On average, observer 1 had the shortest measurements (mean = 368 µm, range = 216–509 µm) and observer 3 had the longest (mean = 374 µm, range = 225–508 µm), with observer 2 (the most experienced observer) in between (mean = 370 µm, range = 208–505 µm). Each circle represents a single ER measurement; the boxes indicate the median and interquartile range with whiskers to the 5th and 95th centile for each observer.
Figure 5.
Figure 5.
Scatter plot matrix showing a high level of agreement between each pair of observers. Pearson's ρ ≥ 0.99 for each pairwise comparison.
Figure 6.
Figure 6.
Bland-Altman plots for electrode to retina (ER) distance for (A) Observer 1 versus 2, (B) Observer 2 versus 3, and (C) Observer 1 versus 3. The mean difference in ER distance between observers ranged from 2.4 to 6.4 µm with limits of agreement (±1.96 SD) shown in grey, representing the range of normal measurement variation relevant clinically. Each circle represents a single measurement location.
Figure 7.
Figure 7.
Example of ER distance measurement variation among observers related to pigment migration/clumping at the RPE. Infrared and accompanying SD-OCT B-scan images. The green arrow indicates the position of the B-scan in the infrared image. Measurement of the ER distance for 2 electrodes as marked by observer 1 (A) and observer 3 (B). Blue box regions show a magnified view of one ER measurement. The 32 µm difference in ER distance between observers in this example is due to a difference in identification of the center of the electrode and local variation in pigment clumping (white arrow) at the inner RPE boundary.
Figure 8.
Figure 8.
Representative comparison of ER distance measures between observers for HR mode compared to HS mode. (A) Infrared and OCT B-scan in HR mode (ART 3, image quality 32) for electrode #B6. (B) Infrared and OCT B-scan in HS mode (ART 40, image quality 34) for electrode #B4. The green arrows indicate B-scan position on the infrared image, the green circles indicate the electrode position measured for each example. The difference in ART between HR and HS mode likely explains the difference in apparent image quality. The agreement was higher between observers in HR mode, which may be due to differences in positioning of the ER distance measurement bar along the X axis, and/or reduced image quality causing smoothing of the RPE boundary line.

References

    1. Liew G, Michaelides M, Bunce C.. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open . 2014; 4: e004015.
    1. Heath Jeffery RC, Mukhtar SA, McAllister IL, et al. .. Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia. Ophthalmic Genet . 2021; 42(4): 431–439.
    1. Ayton LN, Barnes N, Dagnelie G, et al. .. An update on retinal prostheses. Clin Neurophysiol . 2020; 131: 1383–1398.
    1. Allen PJ. Retinal prostheses: Where to from here? Clin Exp Ophthalmol . 2021; 49(5): 418–429.
    1. Cheng DL, Greenberg PB, Borton DA.. Advances in retinal prosthetic research: a systematic review of engineering and clinical characteristics of current prosthetic initiatives. Curr Eye Res . 2017; 42: 334–347.
    1. da Cruz L, Dorn JD, Humayun MS, et al. .. Five-year safety and performance results from the Argus II retinal prosthesis system clinical trial. Ophthalmology . 2016; 123: 2248–2254.
    1. Stingl K, Bartz-Schmidt KU, Besch D, et al. .. Subretinal visual implant alpha IMS–clinical trial interim report. Vis Res . 2015; 111: 149–160.
    1. Ayton LN, Blamey PJ, Guymer RH, et al. .. First-in-human trial of a novel suprachoroidal retinal prosthesis. PLoS One . 2014; 9: e115239.
    1. Edwards TL, Cottriall CL, Xue K, et al. .. Assessment of the electronic retinal implant alpha AMS in restoring vision to blind patients with end-stage retinitis pigmentosa. Ophthalmology . 2018; 125: 432–443.
    1. Delyfer MN, Gaucher D, Mohand-Saïd S, et al. .. Improved performance and safety from Argus II retinal prosthesis post-approval study in France. Acta Ophthalmol . 2021; 99(7): e1212–e1221.
    1. Petoe MA, Titchener SA, Kolic M, et al. .. A second generation (44-channel) suprachoroidal retinal prosthesis: Interim clinical trial results. Transl Vis Sci Technol . 2021; 10: 12.
    1. Karapanos L, Abbott CJ, Ayton LN, et al. .. Functional Vision in the Real-World Environment With a Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis. Transl Vis Sci Technol . 2021; 10: 7.
    1. Sinclair NC, Shivdasani MN, Perera T, et al. .. The appearance of phosphenes elicited using a suprachoroidal retinal prosthesis. Invest Ophthalmol Vis Sci . 2016; 57: 4948–4961.
    1. Abbott CJ, Nayagam DA, Luu CD, et al. .. Safety studies for a 44-channel suprachoroidal retinal prosthesis: a chronic passive study. Invest Ophthalmol Vis Sci . 2018; 59: 1410–1424.
    1. Nayagam DA, Williams RA, Allen PJ, et al. .. Chronic electrical stimulation with a suprachoroidal retinal prosthesis: a preclinical safety and efficacy study. PLoS One . 2014; 9: e97182.
    1. de Balthasar C, Patel S, Roy A, et al. .. Factors affecting perceptual thresholds in epiretinal prostheses. Invest Ophthalmol Vis Sci . 2008; 49: 2303–2314.
    1. Rizzo S, Cinelli L, Finocchio L, et al. .. Assessment of postoperative morphologic retinal changes by optical coherence tomography in recipients of an electronic retinal prosthesis implant. JAMA Ophthalmol . 2019; 137: 272–278.
    1. Yoon YH, Humayun MS, Kim YJ.. One-year anatomical and functional outcomes of the Argus II implantation in Korean patients with late-stage retinitis pigmentosa: A prospective case series study. Ophthalmologica . 2021; 244: 291–300.
    1. Titchener SA, Nayagam DA, Kvansakul J, et al. .. A Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis: Long-Term Observation of the Electrode–Tissue Interface. Transl Vis Sci . 2022; 11: 12.
    1. Butterwick A, Huie P, Jones B, et al. .. Effect of shape and coating of a subretinal prosthesis on its integration with the retina. Exp Eye Res . 2009; 88: 22–29.
    1. Fox K, Meffin H, Burns O, et al. .. Development of a magnetic attachment method for bionic eye applications. Artif Organs . 2016; 40: E12–E24.
    1. Parmeggiani F, De Nadai K, Piovan A, et al. .. Optical coherence tomography imaging in the management of the Argus II retinal prosthesis system. Eur J Ophthalmol . 2017; 27: e16–e21.
    1. Shivdasani MN, Sinclair NC, Dimitrov PN, et al. .. Factors affecting perceptual thresholds in a suprachoroidal retinal prosthesis. Invest Ophthalmol Vis Sci . 2014; 55: 6467–6481.
    1. Ahuja A, Yeoh J, Dorn J, et al. .. Factors affecting perceptual threshold in Argus II retinal prosthesis subjects. Transl Vis Sci Technol . 2013; 2: 1.
    1. Naidu A, Ghani N, Yazdanie MS, et al. .. Effect of the electrode array-retina gap distance on visual function in patients with the Argus II retinal prosthesis. BMC Ophthalmol . 2020; 20: 1–8.
    1. Xu LT, Rachitskaya AV, DeBenedictis MJ, et al. .. Correlation between Argus II array–retina distance and electrical thresholds of stimulation is improved by measuring the entire array. Eur J Ophthalmol . 2021; 31: 194–203.
    1. Pham P, Roux S, Matonti F, et al. .. Post-implantation impedance spectroscopy of subretinal micro-electrode arrays, OCT imaging and numerical simulation: towards a more precise neuroprosthesis monitoring tool. J Neural Eng . 2013; 10: 046002.
    1. Kasi H, Bertsch A, Guyomard J-L, et al. .. Simulations to study spatial extent of stimulation and effect of electrode–tissue gap in subretinal implants. Med Eng Phys . 2011; 33: 755–763.
    1. Stingl K, Bach M, Bartz-Schmidt KU, et al. .. Safety and efficacy of subretinal visual implants in humans: methodological aspects. Clin Exp Optom . 2013; 96: 4–13.
    1. Titchener SA, Kvansakul J, Shivdasani MN, et al. .. Oculomotor responses to dynamic stimuli in a 44-channel suprachoroidal retinal prosthesis. Transl Vis Sci Technol . 2020; 9: 31.
    1. Esteban-Ortega M, Steiner M, García-Lozano I, et al. .. Reproducibility of manual choroidal thickness measurements using optical coherence tomography. Arch Soc Esp Oftalmol . 2020; 95: 379–385.
    1. Chhablani J, Barteselli G, Wang H, et al. .. Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci . 2012; 53: 2274–2280.
    1. Spaide RF, Koizumi H, Pozzoni MC.. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol . 2008; 146: 496–500.
    1. Branchini L, Regatieri CV, Flores-Moreno I, et al. .. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology . 2012; 119: 119–123.
    1. Shao L, Xu L, Chen CX, et al. .. Reproducibility of subfoveal choroidal thickness measurements with enhanced depth imaging by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci . 2013; 54: 230–233.
    1. Flores-Rodríguez P, Gili P, Martín-Ríos MD.. Sensitivity and specificity of time-domain and spectral-domain optical coherence tomography in differentiating optic nerve head drusen and optic disc oedema. Ophthalmic Physiol Opt . 2012; 32: 213–221.
    1. Manjunath V, Taha M, Fujimoto JG, et al. .. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol . 2010; 150: 325–329.e1.
    1. Saunders AL, Williams CE, Heriot W, et al. .. Development of a surgical procedure for implantation of a prototype suprachoroidal retinal prosthesis. Clin Exp Ophthalmol . 2014; 42: 665–674.
    1. SPECTRALIS Diagnostic Imaging Platform from Heidelberg Engineering, Inc., . January 14, 2022.
    1. Giavarina D. Understanding Bland Altman analysis. Biochem Med (Zagreb) . 2015; 25: 141–151.
    1. Landis JR, Koch GG.. A one-way components of variance model for categorical data. Biometrics . 1977; 33(4): 671–679.
    1. Skelly AC, Dettori JR, Brodt ED.. Assessing bias: the importance of considering confounding. Evid Based Spine Care J . 2012; 3: 9–12.

Source: PubMed

3
Abonner